Satellos Bioscience Inc (MSLE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,111 | -1,461 | -1,303 | -955 | -1,125 |
| Depreciation Amortization | 2 | 2 | 1 | 18 | 21 |
| Other Working Capital | 361 | -228 | 456 | -25 | 7 |
| Other Operating Activity | 71 | 0 | 1 | 20 | 91 |
| Operating Cash Flow | $-677 | $-1,686 | $-845 | $-942 | $-1,007 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -5 | -2 | N/A | -3 |
| Investing Cash Flow | $N/A | $-5 | $-2 | $N/A | $-3 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 2,425 | N/A | N/A | N/A |
| Financing Cash Flow | $N/A | $2,425 | $N/A | $N/A | $N/A |
| Exchange Rate Effect | -14 | 5 | -8 | -9 | -43 |
| Beginning Cash Position | 739 | 8 | 863 | 1,821 | 2,835 |
| End Cash Position | 49 | 746 | 8 | 870 | 1,783 |
| Net Cash Flow | $-690 | $738 | $-856 | $-951 | $-1,052 |
| Free Cash Flow | |||||
| Operating Cash Flow | -677 | -1,686 | -845 | -942 | -1,007 |
| Capital Expenditure | N/A | -5 | -2 | N/A | -3 |
| Free Cash Flow | -677 | -1,691 | -848 | -942 | -1,010 |